A new trading day began on Tuesday, with Generation Bio Co (NASDAQ: GBIO) stock price up 4.42% from the previous day of trading, before settling in for the closing price of $0.95. GBIO’s price has ranged from $0.75 to $4.65 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Meanwhile, its annual earnings per share averaged 0.39%. With a float of $42.37 million, this company’s outstanding shares have now reached $66.75 million.
Considering the fact that the conglomerate employs 174 people, you should pay attention to its efficiency factor. In terms of profitability, gross margin is 75.56%, operating margin of -529.6%, and the pretax margin is -782.87%.
Generation Bio Co (GBIO) Breakdown of a Key Holders of the stock
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Generation Bio Co is 36.57%, while institutional ownership is 66.06%. The most recent insider transaction that took place on Jan 10 ’25, was worth 120,759. In this transaction Director of this company bought 125,791 shares at a rate of $0.96, taking the stock ownership to the 214,286 shares. Before that another transaction happened on Jan 13 ’25, when Company’s Director bought 85,000 for $0.97, making the entire transaction worth $82,450. This insider now owns 299,286 shares in total.
Generation Bio Co (GBIO) Recent Fiscal highlights
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.3 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 0.39% per share during the next fiscal year.
Generation Bio Co (NASDAQ: GBIO) Trading Performance Indicators
Here are Generation Bio Co’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 6.34. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 3.56.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -2.19, a number that is poised to hit -0.30 in the next quarter and is forecasted to reach -1.08 in one year’s time.
Technical Analysis of Generation Bio Co (GBIO)
Compared to the last year’s volume of 0.82 million, its volume of 1.03 million showed improvement in the last five days. As of the previous 9 days, the stock’s Stochastic %D was 30.45%. Additionally, its Average True Range was 0.12.
During the past 100 days, Generation Bio Co’s (GBIO) raw stochastic average was set at 10.95%, which indicates a significant decrease from 35.86% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 82.23% in the past 14 days, which was higher than the 80.24% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $1.3146, while its 200-day Moving Average is $2.4371. Nevertheless, the first resistance level for the watch stands at $1.0333 in the near term. At $1.0766, the stock is likely to face the second major resistance level. The third major resistance level sits at $1.1133. If the price goes on to break the first support level at $0.9533, it is likely to go to the next support level at $0.9166. Now, if the price goes above the second support level, the third support stands at $0.8733.
Generation Bio Co (NASDAQ: GBIO) Key Stats
With a market capitalization of 66.12 million, the company has a total of 66,793K Shares Outstanding. Currently, annual sales are 5,900 K while annual income is -126,610 K. The company’s previous quarter sales were 7,550 K while its latest quarter income was -15,310 K.
